Study on Esculetin to reduce cardiotoxicity induced by Doxorubicin

Authors

  • Xiao Li Department of Oncology, Affiliated Hospital of Chengde Medical College, 36 Nanyingzi Street, Shuangqiao, Chengde, Hebei 067000, P.R. China
  • Xiaolei Yu Department of Oncology, Affiliated Hospital of Chengde Medical College, P.R. China
  • Fan Xu Department of Radiology, Affiliated Hospital of Chengde Medical College, P.R. China
  • Qingshan Li Department of Radiology, Affiliated Hospital of Chengde Medical College, P.R. China
  • Xiao Xu Department of Pharmacy, Affiliated Hospital of Chengde Medical College, P.R. China

DOI:

https://doi.org/10.3126/njc.v5i1.41329

Keywords:

doxorubicin, esculetin, Apoptosis

Abstract

Objective: To investigate the protective effects and mechanisms of esculetin(Esc) on H9C2 cells injury induced by doxorubicin (DOX). 

Methods: H9C2 cells were cultured and divided into control group, model (DOX) group and intervention (ESC + DOX) group. Flow cytometry was used to detect apoptosis of H9C2 cells and reactive oxygen (ROS) level in H9C2 cells; Western blotting to detect the cleaved Caspase-3, cleaved PARP, bid and Bcl-2 protein expression in H9C2 cells. 

Results: The number of apoptosis and ROS level of H9C2 cells in the model group, the expression of cleaved Caspase-3, cleaved PARP and Bid protein in the model group were obviously higher than control group; and the Bcl-2 protein expression was obviously lower (P < 0.05).The number of apoptosis and ROS level, cleaved Caspase-3, cleaved PARP and Bid protein expression in H9C2 cells in intervention group were obviously lower than model group;the Bcl-2 protein expression was obviously higher (P< 0.05). 

Conclusion: Esculetin can reduce the cardiotoxicity induced by doxorubicin by reducing apoptosis and ROS level. 

Downloads

Download data is not yet available.
Abstract
85
PDF
98

Downloads

Published

2021-09-26

How to Cite

Li, X., Yu, X., Xu, F., Li, Q., & Xu, X. (2021). Study on Esculetin to reduce cardiotoxicity induced by Doxorubicin. Nepalese Journal of Cancer, 5(1), 70–73. https://doi.org/10.3126/njc.v5i1.41329

Issue

Vol. 5 No. 1 (2021)

Section

Original Articles

License

Copyright (c) 2021 Nepalese Journal of Cancer

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as NJC and the authors are acknowledged.

Submission of the manuscript means that the authors agree to assign exclusive copyright to NJC. The aim of NJC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact.